Tumor grade-associated genomic mutations in Chinese patients with non-small cell lung cancer

BACKGROUND: Lung cancer is the most prevalent cancer worldwide and accounts for approximately 20% of cancer-related death in China every year. High-grade lung cancer poses a significant threat to patients, and developing a novel treatment for these patients requires an understanding of its underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Qin, Shilei, Liang, Yuepei, Yan, Ling, Zheng, Min, Zeng, Yanwu, Lu, Leilei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067928/
https://www.ncbi.nlm.nih.gov/pubmed/37020866
http://dx.doi.org/10.3389/fonc.2023.1119575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067928/
https://www.ncbi.nlm.nih.gov/pubmed/37020866
http://dx.doi.org/10.3389/fonc.2023.1119575

Ejemplares similares